BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6191520)

  • 1. Heterogeneity in electrophoretic mobility of C3-derived molecules expressing D but not C-epitopes following in vivo activation of the complement system.
    Teisner B; Brandslund I; Hau J; Svehag SE
    Acta Pathol Microbiol Immunol Scand C; 1983 Feb; 91(1):85-7. PubMed ID: 6191520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial characterization of physiologically generated C3 components expressing C3d but not C3c epitopes.
    Siersted HC; Jensenius JC; Svehag SE; Brandslund I
    J Clin Lab Immunol; 1983 Dec; 12(4):201-8. PubMed ID: 6198522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The third complement factor (C3) and its in vivo cleavage products: interaction with lectins and precipitation with polyethylene glycol.
    Teisner B; Hau J; Svehag SE; Brandslund I; Bøg-Hansen TC
    J Immunol Methods; 1984 Jan; 66(1):113-8. PubMed ID: 6607289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Charge and size heterogeneity of C3d following in vivo and in vitro activation of the complement system.
    Teisner B; Hau J; Folkersen J; Jepsen HH
    Complement; 1984; 1(1):36-43. PubMed ID: 6085760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and clinical application of electroimmunoassays for the direct quantification of the complement C3 split products C3c and C3d.
    Brandslund I; Teisner B; Hyltoft Petersen P; Svehag SE
    Scand J Clin Lab Invest Suppl; 1984; 168():57-73. PubMed ID: 6333715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement activation during normal pregnancy.
    Teisner B; Grudzinskas JG
    Placenta Suppl; 1982; 4():119-24. PubMed ID: 6985440
    [No Abstract]   [Full Text] [Related]  

  • 7. Complement activation in shock associated with a surgically provoked bacteriaemia.
    Brandslund I; Teisner B; Hole P; Grudzinskas JG; Svehag SE
    Acta Pathol Microbiol Immunol Scand C; 1983 Feb; 91(1):51-7. PubMed ID: 6603095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute complement activation during an anaphylactoid reaction to blood transfusion and the disappearance rate of C3c and C3d from the circulation.
    Teisner B; Brandslund I; Grunnet N; Hansen LK; Thellesen J; Svehag SE
    J Clin Lab Immunol; 1983 Oct; 12(2):63-7. PubMed ID: 6606048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of C3 conversion by ELISA estimation of neo-determinants on the C3d moiety.
    Holmskov-Nielsen U; Jensenius JC; Teisner B; Erb K
    J Immunol Methods; 1986 Nov; 94(1-2):1-6. PubMed ID: 2431062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating C3, C4, and C3 split products (C3c and C3d) during normal pregnancy.
    Teisner B; Hau J; Tucker M; Lahood J; Grudzinskas JG
    Am J Reprod Immunol (1980); 1982 Dec; 2(6):309-11. PubMed ID: 6984294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rocket immunoelectrophoresis of C3 and C3d: a simple sensitive method for detecting complement activation in plasma].
    Hou JC; Lin YL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1986 Feb; 8(1):58-63. PubMed ID: 2943446
    [No Abstract]   [Full Text] [Related]  

  • 12. Determination of complement breakdown fragments C3d and its subfragments in health and disease.
    Tamotsu M; Arai K; Fujita S; Hosotsubo K; Hayashi C; Miyai K; Miyano A; Kawanaka K; Takenaka M; Shimizu A
    Diagn Immunol; 1984; 2(2):116-21. PubMed ID: 6333963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical applications of crossed immunoelectrophoresis to the study of complement activation.
    Yewdall VM; Boscoe MJ; Bennett-Jones DN; Cameron JS
    J Clin Lab Immunol; 1987 Oct; 24(2):51-6. PubMed ID: 3437439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlation of hepatic necrosis and complement system activation in fulminant viral hepatitis].
    Hou J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1993 Feb; 15(1):49-54. PubMed ID: 8324837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cleavage of the complement system C3 component by HIV-1 proteinase.
    Kisselev AF; Mentele R; von der Helm K
    Biol Chem; 1997 May; 378(5):439-42. PubMed ID: 9191031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement activation during cardiopulmonary bypass in infants and children. Relation to postoperative multiple system organ failure.
    Seghaye MC; Duchateau J; Grabitz RG; Faymonville ML; Messmer BJ; Buro-Rathsmann K; von Bernuth G
    J Thorac Cardiovasc Surg; 1993 Dec; 106(6):978-87. PubMed ID: 8246580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the complement system and leukocyte recruitment by Tityus serrulatus scorpion venom.
    Bertazzi DT; de Assis-Pandochi AI; Talhaferro VL; Caleiro Seixas Azzolini AE; Pereira Crott LS; Arantes EC
    Int Immunopharmacol; 2005 Jun; 5(6):1077-84. PubMed ID: 15829423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement C3c and C3d in plasma and synovial fluid in rheumatoid arthritis.
    Berkowicz A; Kappelgaard E; Petersen J; Nielsen H; Ingemann-Hansen T; Halkjaer-Kristensen J; Sørensen H
    Acta Pathol Microbiol Immunol Scand C; 1983 Dec; 91(6):397-402. PubMed ID: 6608857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Selective binding in vitro of a modified form of the C3 component of complement to human erythrocytes].
    Micouin C; Hudry-Clergeon E; Roussel B; Battail N; Tournoud A; Colomb MG
    Ann Immunol (Paris); 1983; 134C(2):237-53. PubMed ID: 6223572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The quantitation of C3d by routine methods after the direct absorption of human plasma with anti-C3c.
    Mlynek Y; Nilsson M
    Acta Pathol Microbiol Immunol Scand C; 1985 Oct; 93(5):195-8. PubMed ID: 3936336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.